Czech National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270M Buy
225,167
+9,355
+4% +$9.56M 1.47% 11
2026
Q1
$198M Buy
215,812
+6,413
+3% +$6.5M 1.3% 12
2025
Q4
$225M Buy
209,399
+7,480
+4% +$7.15M 1.46% 12
2025
Q3
$154M Buy
201,919
+9,641
+5% +$7.17M 1.06% 12
2025
Q2
$150M Buy
192,278
+11,302
+6% +$8.78M 1.17% 12
2025
Q1
$149M Buy
180,976
+10,136
+6% +$8.43M 1.37% 12
2024
Q4
$132M Buy
170,840
+10,143
+6% +$8.4M 1.22% 12
2024
Q3
$142M Buy
160,697
+8,566
+6% +$7.7M 1.44% 11
2024
Q2
$138M Buy
152,131
+11,825
+8% +$9.46M 1.58% 9
2024
Q1
$109M Buy
140,306
+620
+0.4% +$441K 1.41% 9
2023
Q4
$81.4M Buy
139,686
+315
+0.2% +$184K 1.16% 13
2023
Q3
$74.9M Buy
139,371
+46,100
+49% +$23.8M 1.19% 12
2023
Q2
$43.7M Buy
93,271
+330
+0.4% +$138K 0.99% 15
2023
Q1
$31.9M Buy
92,941
+525
+0.6% +$177K 0.79% 20
2022
Q4
$33.8M Buy
92,416
+764
+0.8% +$271K 0.9% 18
2022
Q3
$29.6M Buy
+91,652
New +$29M 0.85% 18

Other funds holding LLY

Czech National Bank's LLY Position: Q2 2026 in Review

Czech National Bank increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $9.56M and bringing the position to 225,167 shares worth $270M. The position accounts for 1.47% of the portfolio, ranked #11.

Czech National Bank first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Czech National Bank held 225,167 shares of Eli Lilly worth $270M as of Q2 2026.
  • Czech National Bank bought 9,355 Eli Lilly shares in Q2 2026, an estimated $9.56M.
  • Eli Lilly made up 1.47% of Czech National Bank's portfolio in Q2 2026, its #11 holding.
  • Czech National Bank first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.